| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 5 | CY 1 | 99.95 |
| Antibiotic Resistance in Bacteria | Lifetime | 8 | CY 1 | 99.96 |
| Pneumonia and Respiratory Infections | Lifetime | 10 | CY 1 | 99.90 |
| Antibiotic Use and Resistance | Lifetime | 8 | CY 1 | 99.89 |
| Urinary Tract Infections Management | Lifetime | 12 | CY 1 | 99.80 |
| Nosocomial Infections in ICU | Lifetime | 11 | CY 1 | 99.78 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 40 | CY 1 | 99.58 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 63 | CY 1 | 99.56 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 94 | CY 1 | 99.42 |
| Health and Medical Research Impacts | Lifetime | 36 | CY 1 | 98.45 |
| Surgical site infection prevention | Lifetime | 46 | CY 1 | 98.84 |
| scientometrics and bibliometrics research | Lifetime | 29 | CY 1 | 98.47 |
| Streptococcal Infections and Treatments | Lifetime | 183 | CY 1 | 98.75 |
| Infectious Diseases and Tuberculosis | Lifetime | 234 | CY 1 | 97.81 |
| Cytomegalovirus and herpesvirus research | Lifetime | 492 | CY 1 | 97.87 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 476 | CY 2 | 98.15 |
| Central Venous Catheters and Hemodialysis | Lifetime | 327 | CY 3 | 97.63 |
| Antifungal resistance and susceptibility | Lifetime | 472 | CY 1 | 97.53 |
| Cystic Fibrosis Research Advances | Lifetime | 415 | CY 1 | 96.77 |
| Infections and bacterial resistance | Lifetime | 84 | CY 1 | 96.18 |
| Neutropenia and Cancer Infections | Lifetime | 526 | CY 1 | 95.78 |
| Meta-analysis and systematic reviews | Lifetime | 356 | CY 1 | 95.57 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 834 | CY 1 | 94.72 |
| Academic Publishing and Open Access | Lifetime | 46 | CY 1 | 93.39 |
| Academic Writing and Publishing | Lifetime | 43 | CY 1 | 92.34 |
| Otolaryngology and Infectious Diseases | Lifetime | 246 | CY 1 | 90.82 |
| Social Media in Health Education | Lifetime | 327 | CY 1 | 91.15 |
| History of Medicine Studies | Lifetime | 363 | CY 1 | 84.31 |
| Infection Control in Healthcare | Lifetime | 891 | CY 1 | 81.24 |
| Dermatological and COVID-19 studies | Lifetime | 734 | CY 1 | 76.71 |
| Pharmaceutical Quality and Counterfeiting | Lifetime | 247 | CY 1 | 76.10 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 580 | CY 1 | 73.18 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 907 | CY 1 | 81.29 |
